BioWorld

Oct. 8, 2002

McClellan Breezes Through First Meeting Before Senate Committee

WASHINGTON - Nominee Mark McClellan easily jumped the first hurdle in becoming the next commissioner of the FDA from a largely absent Senate committee. (Bioworld Today) Read More

New Erbitux Trials Starting; ImClone Has Second Chance'

Phylogeny Test Opens Novel Path To Forensic Crime Detection, First In U.S.; Forecast As Future Model

Cell Therapeutics Starts NSCLC Phase III, Eyes One More In 2002

Quorex Enhances Platform By Acquiring Bioinformatics Firm

Other News To Note

Appointments And Advancements

Today's news in brief

BioWorld

BioWorld briefs for June 9, 2026.

ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins

BioWorld

If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...

Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors

BioWorld Science

Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.